Simplifying Global Compliance
Articles Tagged with ''Industry News''
Magnetic resonance imaging (MRI) can detect cancer in the second, or contralateral, breast in women with breast cancer, even when it is missed by mammography and clinical examination during the initial breast-cancer diagnosis, a study in the March 29 issue of the New England Journal of Medicince says. Read More
The clinical benefit of computer-aided detection to assist radiologists in interpreting mammograms is uncertain, a recent study found. Read More
Stents have not been successful enough in treating chronic total artery blockage, or chronic total occlusion (CTO), leaving room for new techniques and devices, a recent study says. Read More
Genentech announced that its operating revenue in the first quarter of 2007 totaled $2.84 billion, up 43 percent from $1.99 billion last year. Read More
Wyeth will respond this month to Form 483 observations from an FDA reinspection of the company’s Guayama, Puerto Rico, manufacturing facility, the firm recently announced. Read More
Omnicare has entered into a contract with Cardinal Health’s repackaging unit following the long-term care pharmacy’s closure of its Heartland operation, the companies recently announced. Read More
Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson, has recalled an estimated 200,000 units of anti-fungal Grifulvin V because of two reports that glass fragments were found in bottles of the oral suspension, the firm announced April 10. Read More
Payment rates under Medicare's durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) fee schedule will be changing soon. Read More
The UK Department of Health (DoH) is urging all medical technology and medicines manufacturers to use the GS1 autoidentification and data capturing (AIDC) system for tracking products supplied to the English National Health System (NHS). Read More
Development of unique device identification (UDI), similar to the bar codes on drugs and biological products, could vastly improve the U.S. Food and Drug Administration’s (FDA) ability to respond to adverse events and track recalls, Jeff Crowley, the FDA’s senior adviser for patient safety, said. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing